OptimizeRx Survey Shows Providers Want to Engage with Patients on Drug Costs for Adherence and Improved Care
Released in partnership with
The cost of prescription drugs is on the mind of physicians and patients alike.
- The vast majority of patients raise the issue of the cost of prescription drugs with their doctors
- Most physicians (86 percent) are comfortable discussing health care costs with patients and over 90 percent believe they have a role to play in discussing healthcare costs with patients
- 73 percent of physicians feel patient’s responsibility for cost is important when making a prescribing decision
Physicians believe a variety of factors that lead to unfilled prescriptions, including:
- The high costs of prescribed medicines (70 percent)
- Intolerable or unpleasant side effects (45 percent)
- A patient’s desire not to take pills (34 percent)
- Patients already taking too many pills (31 percent)
While doctors believe they understand the reasons for patients not filling prescriptions, too few physicians track when patients haven’t filled that script:
- Only 5 percent of doctors “always” track an unfilled prescription and 18 percent “usually” do so
- Taken together, that means that three-quarters of doctors are not tracking unfilled prescriptions
“According to a recent study, lack of medication adherence costs the U.S. health system as much as
The survey was the first to be executed through OptimizeMDs, a multi-specialty physician panel created by
The cloud-based solution supports patient adherence to medications and better healthcare outcomes with real-time access to financial assistance, prior authorization, education and critical clinical information. OptimizeRx provides more than half of the ambulatory patient market with access to these benefits through leading EHR platforms like Allscripts, Amazing Charts and Quest, and directly via its mobile communications platform.
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
Tel (248) 651-6568 x807
Media Relations Contact
Investor Relations Contact
Tel (949) 432-7557
Source: OptimizeRx Corporation